22 February 2002
Tumor markers in metastatic disease from cancer of unknown primary origin.Ivan Popov, Marijana Milović, Svietislav Jelić
Med Sci Monit 2002; 8(2): MT25-30 :: ID: 420926
BACKGROUND: About 5-10% of cancer patients suffer from cancer of unknownprimary (CUP). Sophisticated diagnostic techniques have not improved diagnostic efficacy for these patients.The aim of our analysis was to evaluate serum levels of four tumor markers and to relate them to thehistology, number, and sites of metastases, the response to chemotherapy, and survival. MATERIAL/METHODS:Blood samples from 46 patients with CUP were assayed for CEA, CA 19-9, CA 15-3 and CA 125. Specific IMxtumor marker assays (Abbott) were used to measure tumor marker quantities. RESULTS: No significant differenceswere detected between the mean levels of all markers for the two histological types (adenocarcinoma vs.undifferentiated carcinoma). The comparison of tumor marker values in patients with one metastatic locationto those with two or more showed no significant differences. We found no differences in marker valuesbetween patients with disease sites in the thorax vs. those with abdominal metastases. The comparisonof marker negative, CEA positive and non-CEA positive patients failed to reveal significant differencesin response rate. The comparison of CEA positive and marker negative patients showed significant differencesin survival (log-rank, p=0.02). CONCLUSIONS: Our results suggest that patients with CUP have a nonspecificoverexpression of serum tumor markers and that routine use of these markers does not offer diagnosticassistance. Nevertheless, the pattern of expression of some biological markers, such as CEA, could haveprognostic significance for survival.
Keywords: Neoplasms, Unknown Primary, Tumor Markers, Biological
01 June 2023 : EditorialEditorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness
Med Sci Monit 2023; 29:e941209
01 Jun 2023 : Clinical ResearchRoot Canal Numbers and Configurations in 1080 Permanent Canine Teeth in 270 Saudi Subjects Using Cone-Beam ...
Med Sci Monit In Press; DOI: 10.12659/MSM.940472
01 Jun 2023 : Clinical ResearchInternal Orifice Alloy Closure: A New Procedure for Treatment of Perianal Fistulizing Crohn’s Disease
Med Sci Monit In Press; DOI: 10.12659/MSM.940873
01 Jun 2023 : Clinical ResearchEffectiveness of Needle Aspiration versus Surgical Excision for Symptomatic Synovial Cysts of the Hip: A Si...
Med Sci Monit In Press; DOI: 10.12659/MSM.940187
01 Jun 2023 : Clinical ResearchInfluence of Insulin Resistance on Diabetes Nephropathy
Med Sci Monit In Press; DOI: 10.12659/MSM.939482
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952